Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa - 14/10/15
Abstract |
Traditional systemic therapies are frequently prescribed for the treatment of hidradenitis suppurativa (HS). Clinicians consider antibiotics, retinoids, antiandrogens, immunosuppressants, and less common treatment, such as fumarates, in the management of HS. Different classes of medications have been selected to treat HS based on their ability to target various pathways of the condition. Concerns about infection, such as infection with Clostridium difficile, necessitates switching therapy or shortening the course of therapy with specific antibiotics. This review explores the outcomes with the use of numerous medical therapies and postulates explanations for their efficacy or lack of response. Data on long-term safety and efficacy with traditional systemic therapies are lacking.
Le texte complet de cet article est disponible en PDF.Key words : antiandrogens, antibacterials, evidence-based medicine, fumarates, hidradenitis suppurativa, immunosuppressants, retinoids, zinc
Plan
This publication was supported through funding provided by AbbVie Corporation. |
|
Disclosure: Dr Alhusayen has served as a consultant, advisory board member and/or study investigator for AbbVie and Janssen. Dr Shear has served as a consultant, advisory board member and/or received honoraria for lecturing for AbbVie, Amgen, Celgene, Hospira, Janssen, Leo Pharma, Eli Lilly, and Novartis. |
Vol 73 - N° 5S1
P. S42-S46 - novembre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?